As always, consult with your healthcare provider to determine what is best for you
A survey by benefits consultant Mercer found 49% of large employers covered GLP-1 medications in 2025, up from 41% in 2023
Starc A, Trampu M, Juki DP, Rotim C, Juki T, Mivek AP Infertility and sexual dysfunctions: A systematic literature review
It can help support the appearance of mild unevenness and pigmentation over time, especially when paired with sunscreen and consistent use
For researchers interested in the most advanced published efficacy data regardless of regulatory status, retatrutides TRIUMPH results represent the fields current leading edge
GLP 1 Receptor Agonist Cardiovascular Therapy Market Size, Share, Revenue Report 2026 to 2035 What is GLP 1 Receptor Agonist Cardiovascular Therapy Market